Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy

Coverage, in order

1. 2d ago
   
   MedCity News indie study

   Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy

   Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that reset the immune…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.